Artwork

内容由Drug Discovery World and Drug Discovery World (DDW)提供。所有播客内容(包括剧集、图形和播客描述)均由 Drug Discovery World and Drug Discovery World (DDW) 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Drug discovery success stories

12:07
 
分享
 

Manage episode 380371018 series 1919400
内容由Drug Discovery World and Drug Discovery World (DDW)提供。所有播客内容(包括剧集、图形和播客描述)均由 Drug Discovery World and Drug Discovery World (DDW) 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

This is the latest episode of the free DDW narrated podcast, “Drug discovery success stories", which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Global pharma start-up success stories”, and “Excitement at rectal cancer immunotherapy breakthrough”.

In the first article, Lu Rahman selects some interesting global start-ups pushing the boundaries in drug discovery, from AI to £D deep-learning research to biologics.

In the second article, we explore a groundbreaking ‘immuno-ablative’ neo- adjuvant immunotherapy clinical trial that Memorial Sloan Kettering Cancer Center (MSK) has reported has having had a 100% complete response rate in MMRd locally advanced rectal cancer.

  continue reading

155集单集

Artwork
icon分享
 
Manage episode 380371018 series 1919400
内容由Drug Discovery World and Drug Discovery World (DDW)提供。所有播客内容(包括剧集、图形和播客描述)均由 Drug Discovery World and Drug Discovery World (DDW) 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

This is the latest episode of the free DDW narrated podcast, “Drug discovery success stories", which covers two articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “Global pharma start-up success stories”, and “Excitement at rectal cancer immunotherapy breakthrough”.

In the first article, Lu Rahman selects some interesting global start-ups pushing the boundaries in drug discovery, from AI to £D deep-learning research to biologics.

In the second article, we explore a groundbreaking ‘immuno-ablative’ neo- adjuvant immunotherapy clinical trial that Memorial Sloan Kettering Cancer Center (MSK) has reported has having had a 100% complete response rate in MMRd locally advanced rectal cancer.

  continue reading

155集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南